JO
LNAI

John Overdeck’s Lunai Bioworks LNAI Stock Holding History

John Overdeck’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,052
Closed -$2.14K – 4362
2025
Q3 		$2.14K Buy
+2,052
New +$39.6K ﹤0.01% 3628
2025
Q2 		– Sell
-354
Closed -$15.4K – 3479
2025
Q1 		$15.4K Buy
354
+57
+19% +$3.65K ﹤0.01% 3120
2024
Q4 		$19.8K Buy
297
+16
+6% +$1.06K ﹤0.01% 3112
2024
Q3 		$10.9K Buy
+281
New +$19.5K ﹤0.01% 3046
2023
Q3 		– Sell
-388
Closed -$17.6K – 3168
2023
Q2 		$17.6K Sell
388
-314
-45% -$24.1K ﹤0.01% 2915
2023
Q1 		$51.4K Sell
702
-419
-37% -$36.9K ﹤0.01% 2751
2022
Q4 		$92.4K Sell
1,121
-629
-36% -$84.4K ﹤0.01% 2519
2022
Q3 		$253K Sell
1,750
-609
-26% -$111K ﹤0.01% 2021
2022
Q2 		$364K Buy
+2,359
New +$1.08M ﹤0.01% 1952

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $995M AUM 22.79% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

John Overdeck's LNAI Position: Q4 2025 in Review

John Overdeck sold out of Lunai Bioworks (LNAI) in Q4 2025, closing a stake of 2,052 shares — an estimated $2.14K sold.

John Overdeck first reported a position in LNAI in Q2 2022 and held it in 9 quarters. The position peaked at $364K in Q2 2022. 22 funds tracked by Wall St. Rank hold LNAI as of Q4 2025.

  • John Overdeck reported no remaining Lunai Bioworks position as of Q4 2025 after selling out during the quarter.
  • John Overdeck sold 2,052 Lunai Bioworks shares in Q4 2025, an estimated $2.14K.
  • John Overdeck first reported a position in Lunai Bioworks in Q2 2022 and held it in 9 quarters.
  • John Overdeck's Lunai Bioworks position peaked at $364K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.